Paper795299
Are agents affecting platelet functions clinically useful?
Verstraete M. Am J Med, 1976. Cited by 69 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Are agents affecting platelet functions clinically useful? Papers, record 795299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/795299
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arterial Occlusive Diseases | Major topic |
| Blood Platelets | Major topic |
| Thrombophlebitis | Major topic |
| Thrombosis | Major topic |
| Aged | |
| Animals | |
| Aspirin | |
| Clofibrate | |
| Dextrans | |
| Dipyridamole | |
| Dogs | |
| Heparin | |
| Humans | |
| Male | |
| Platelet Aggregation | |
| Thromboembolism |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,745,127 | Aspirin in the prevention of myocardial infarction. Current status. | Drugs | 1984 | https://conductscience.org/library/papers/6745127 | PubMed |
| 3,525,085 | Current issues in thrombosis prevention with antiplatelet drugs. | Drugs | 1986 | https://conductscience.org/library/papers/3525085 | PubMed |
| 2,191,733 | Coronary artery bypass surgery. | BMJ | 1990 | https://conductscience.org/library/papers/2191733 | PubMed |
| 657,992 | Antiplatelet agents in coronary disease: are they of prophylactic value? | Drugs | 1978 | https://conductscience.org/library/papers/657992 | PubMed |
| 508,556 | The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/508556 | PubMed |
| 487,958 | Role of antiplatelet agents in cerebrovascular disease. | Drugs | 1979 | https://conductscience.org/library/papers/487958 | PubMed |
| 466,100 | Can we really prevent postoperative pulmonary emboli? | Br Med J | 1979 | https://conductscience.org/library/papers/466100 | PubMed |
| 413,839 | Inhibition of platelet prostaglandin synthetase by oral aspirin. | J Clin Invest | 1978 | https://conductscience.org/library/papers/413839 | PubMed |
| 392,079 | A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction. | J R Coll Gen Pract | 1979 | https://conductscience.org/library/papers/392079 | PubMed |
| 391,530 | Antiplatelet drugs: clinical pharmacology and therapeutic use. | Drugs | 1979 | https://conductscience.org/library/papers/391530 | PubMed |
| 291,066 | 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/291066 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/795299
GET https://conductscience.org/api/papers/v1/795299/authors